首页GRAL • NASDAQ
add
Grail Inc
昨日收盘价
$38.65
当日价格范围
$36.87 - $38.47
年度波幅
$12.33 - $63.99
市值
13.71亿 USD
平均交易量
79.42万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
(USD) | 2025年6月info | 年同比变化 |
---|---|---|
收入 | 3554.40万 | 11.18% |
经营支出 | 1.47亿 | -37.88% |
净收入 | -1.14亿 | 92.81% |
净利润率 | -320.69 | 93.53% |
每股收益 | -3.18 | — |
息税折旧摊销前利润 | -9167.90万 | 49.34% |
有效税率 | 25.43% | — |
资产负债表
总资产
负债总额
(USD) | 2025年6月info | 年同比变化 |
---|---|---|
现金及短期投资 | 6.03亿 | -37.14% |
总资产 | 27.03亿 | -17.34% |
负债总额 | 3.88亿 | -32.48% |
权益总额 | 23.15亿 | — |
发行在外的股份 | 3604.78万 | — |
市净率 | 0.60 | — |
资产回报率 | -11.79% | — |
资本回报率 | -13.48% | — |
现金流
现金净变动
(USD) | 2025年6月info | 年同比变化 |
---|---|---|
净收入 | -1.14亿 | 92.81% |
来自运营的现金 | -7696.50万 | 55.20% |
投资现金 | 7036.90万 | 5,177.13% |
融资现金 | — | — |
现金净变动 | -646.80万 | -100.85% |
自由现金流 | -2988.18万 | 75.95% |
简介
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Wikipedia
成立时间
2015
员工数量
1,000